I have written several articles on the coronavirus and on masks and healthcare issues. A series of links have been provided at the bottom of this article for your convenience. This article will, however address a different aspect of the virus or on healthcare issues in general.
In September 2020, India was confirming nearly 100,000 new coronavirus cases a day. It was on track to overtake the United States to become the country with the highest reported COVID-19 caseload in the world. Hospitals were full. The Indian economy nosedived into an unprecedented recession.
But four months later, India’s coronavirus numbers have plummeted. Late last month, on Jan. 26, the country’s Health Ministry confirmed a record low of about 9,100 new daily cases — in a country of nearly 1.4 billion people. It was India’s lowest daily tally in eight months. On Monday, India confirmed about 11,000 cases.
“It’s not that India is testing less or things are going underreported,” says Jishnu Das, a health economist at Georgetown University. “It’s been rising, rising — and now suddenly, it’s vanished! I mean, hospital ICU utilization has gone down. Every indicator says the numbers are down.”
Scientists say it’s a mystery. They’re probing why India’s coronavirus numbers have declined so dramatically — and so suddenly, in September and October, months before any vaccinations began.
They’re trying to figure out what Indians may be doing right and how to mimic that in other countries that are still suffering.Article continues after sponsor message
“It’s the million-dollar question. Obviously, the classic public health measures are working: Testing has increased, people are going to hospitals earlier and deaths have dropped,” says Genevie Fernandes, a public health researcher with the Global Health Governance Programme at the University of Edinburgh. “But it’s really still a mystery. It’s very easy to get complacent, especially because many parts of the world are going through second and third waves. We need to be on our guard.”
Scholars are examining India’s mask mandates and public compliance, as well as its climate, its demographics and patterns of diseases that typically circulate in the country.
Mask and mandates
India is one of several countries — mostly in Asia, Africa and South America — that have mandated masks in public spaces. Prime Minister Narendra Modi appeared on TV wearing a mask very early in the coronavirus pandemic. The messaging was clear.
In many Indian municipalities, including the megacity Mumbai, police hand out tickets — fines of 200 rupees ($2.75) — to violators. Mumbai’s mask mandate even applies outdoors, to joggers on the beach and passengers in open-air rickshaws.
“Every time they fine a person 200 rupees, they also give them a mask to wear,” explains Fernandes, a Mumbai native. “Very stereotypically, we [Indians] are known to break rules! You see traffic rules being broken all the time,” she says, laughing.
But in the pandemic, when it comes to masks, “the police, the monitoring, enforcement — all that was ramped up,” she says.
Authorities reportedly collected the equivalent of $37,000 in mask fines in Mumbai on New Year’s Eve alone.
But the fines and mandates appear to have worked: In a survey published in July, 95% of respondents said they wore a mask the last time they went out. The survey was conducted by phone in June by the National Council of Applied Economic Research, India’s biggest independent economic policy group.
Awareness is widespread. Whenever you make a phone call in India — on landlines and mobiles — instead of a ring tone, you hear government-sponsored messages warning you to wash your hands and wear a mask. One message was recorded by Bollywood legend Amitabh Bachchan, 78, who battled and recovered from COVID-19 last summer.
The mask and hand-washing messages have now been replaced with new ones urging people to get vaccinated; India began vaccinations on Jan. 16.
Heat and humidity
Aside from mask compliance, there’s also India’s climate: Most of the country is hot and humid. That too has deepened the mystery. There’s some evidence that India’s climate may help reduce the spread of respiratory viruses. But there’s also some evidence to the contrary.
A review of hundreds of scientific articles, published in September in the journal PLOS One, found that warm and wet climates seem to reduce the spread of COVID-19. Heat and humidity combine to render coronaviruses less active — though the certainty of that conclusion, the review says, is low. Previous research has also found that droplets of the virus may stay afloat longer in air that’s cold and dry.
“When the air is humid and warm, [the droplets] fall to the ground more quickly, and it makes transmission harder,” Elizabeth McGraw, director of the Center for Infectious Disease Dynamics at Pennsylvania State University, told NPR last year. (However, the science of transmission is still evolving.)
In a survey of COVID-19 cases in India’s Punjab state, Das, the health economist at Georgetown, found that 76% of patients there did not infect a single other person — though it’s unclear why. He and his colleagues examined data collected from contact tracing and found that most patients who did infect others infected only a few other people, while a few patients infected many. Overall, 10% of cases accounted for 80% of infections. One implication, which Das says he’s investigating further, is the possibility of making contact tracing more efficient by first testing a patient’s immediate family members. If no one at all is infected, the process can end there.
“The temperature, of course, is in our favor. We do not have too cold of a climate,” says Dr. Daksha Shah, an epidemiologist and deputy executive health officer for the city of Mumbai. “So many viruses are known to multiply more in colder regions.”
But there’s also some scientific evidence to the contrary, that India might actually be more conducive to the coronavirus: Research published in December in the journal GeoHealth says that urban India’s severe air pollution might exacerbate COVID-19. Not only does pollution weaken the body’s immune system, but when air is thick with pollutants, those particles may help buoy the virus, allowing it to stay airborne longer.
A paper published in July in The Lancet says extreme heat may also force people indoors, into air-conditioned spaces — and thus might contribute to the virus’s spread. The Natural Resources Defense Council has warned that extreme heat can lead to a spike in other illnesses — dehydration, diarrhea — that might lead to overcrowding in hospitals and clinics already struggling to treat victims of COVID-19.
Prevalence of other diseases
Another point to consider about India is how many other diseases are already rampant: malaria, dengue fever, typhoid, hepatitis, cholera. Millions of Indians also lack access to clean drinking water, sanitation and hygienic food. Some experts speculate that people with robust immune systems may be more likely to survive in India in the first place.
“All of us have pretty good immunity! Look at the average Indian: He or she has probably had malaria at some point in his life or typhoid or dengue,” says Sayli Udas-Mankikar, an urban policy expert at the Observer Research Foundation in Mumbai. “You end up with basic immunity toward grave diseases.”
Two new scientific papers support that thesis, though they have yet to be peer-reviewed: One study by Indian scientists from Chennai and Pune, published in October, found that low- and lower-middle-income countries with less access to health care facilities, hygiene and sanitation actually have lower numbers of COVID-19 deaths per capita. Another study by scientists at India’s Dr. Rajendra Prasad Government Medical College, published in August, found that COVID-19 deaths per capita are lower in countries where people are exposed to a diverse range of microbes and bacteria.
But experts warn that these two studies are preliminary and should serve only as a springboard for more investigation.
“They’re not based on any biological data. So they’re good for generating a hypothesis, but now we really need to do the studies that will result in explanations,” says Dr. Gagandeep Kang, an infectious diseases researcher at the Christian Medical College in Vellore. “I hope scientists work more on this soon. We need deeper dives into India’s immune responses.”
According to Health Ministry figures, the coronavirus has killed 154,392 people in India as of Feb. 1. That’s a mortality rate of 1.44% — much lower than that of the United States or many European countries. (But Brazil’s death rate is higher than India’s, and Brazil and India are both lower-middle-income countries.)
India is a very young country as well. Only 6% of Indians are older than 65. More than half the population is under 25. Those who are young are less likely to die of COVID-19 and are more likely to show no symptoms if infected.
A study of nearly 85,000 coronavirus cases in India, published in November in the journal Science, found that the COVID-19 mortality rate actually decreases there after age 65 — possibly because Indians who live past that age are such outliers. There are so few of them.
“Those Indians who do live that long tend to be more healthy than average or more wealthy — or both,” says health economist Das.
Serological surveys — random testing for antibodies — show that a majority of people in certain areas of India may have already been exposed to the coronavirus, without developing symptoms. Last week, preliminary findings from a fifth serological study of 28,000 people in India’s capital showed that 56% of residents already have antibodies, though a final report has not yet been published. The figures were higher in more crowded areas. Last summer, another survey by Mumbai’s health department and a government think tank found that 57% of Mumbai slum-dwellers and 16% of people living in other areas had antibodies suggesting prior exposure to the coronavirus.
But many experts caution that herd immunity — a controversial term, they say — would only begin to be achieved if at least 60% to 80% of the population had antibodies. It’s also unclear whether antibodies convey lasting immunity and, if so, for how long. More serological surveys are needed, they say.
India’s climate and demographics have not changed during the pandemic. And the drop in India’s COVID-19 caseload has been recent. It hit a peak in September and has declined inexplicably since then.
In fact, India’s numbers went down exactly when experts predicted they would spike: in October, when millions of people gathered for the Hindu festivals of Diwali and Durga Puja. It’s when air pollution is also worst, and experts feared that would exacerbate the pandemic too.
Cases have also declined despite what many thought would be a superspreader event: tens of thousands of Indian farmers camping out on the capital’s outskirts for months.
Shah, the epidemiologist, wonders if, just like more infectious variants of the coronavirus have been discovered in the U.K. and elsewhere, perhaps a milder variant may have started mutating in India.
“Some processes must have happened. This is an evolution of the virus itself. In some places there are mutations happening,” she says. “We need some more deeper evidence and deeper studies.”
The truth is, scientists just don’t know.
“Three options: One is that it’s gone because of the way people behaved, so we need to continue that behavior. Or it’s gone because it’s gone and it’s never going to come back — great!” says Das, from Georgetown. “Or it’s gone, but we don’t know why it’s gone — and it may come back.”
That last option is what keeps scientists and public health experts up at night.
So for now, Indians are kind of holding their breath — just doing what they’re doing — until they get vaccinated.
With India reeling under the deadly second wave of COVID-19 pandemic, the government has taken 11 steps to fight the disease as Akhilesh Mishra delves into it in detail. After some harrowing weeks, a glimmer of hope maybe finally emerging in India’s war against the second wave of the COVID-19 pandemic. The graph of daily new cases (Graph 01) as well as the more reliable graph of seven-day moving average of new cases (Graph 02) is now showing a sustained dip. The new cases versus recoveries graph (Graph 03) is also now in the green with daily recoveries now overshooting the new cases.
An important question, that has especially raged in the international media, is what has the response of the Government of India been in tackling the pandemic? The response can be summarized in eleven brackets.
Task Force on Corona Vaccine and other Science and Technology Issues was constituted as early as constituted on April 14, 2020. Within just 9 months, the roll-out of COVID-19 vaccine started across the country on Jan 16, 2021.
The current production capacity of indigenously developed Covaxin vaccine is slated to be doubled by May-June 2021 and then increased nearly 6-7-fold by July-August 2021 i.e increasing the production from 10 million vaccine doses in April 2021 to 60-70 million vaccine dose/month in July – August. It is expected to reach nearly 100 million doses per month by Sep 2021.
Combined with other approved vaccines like Covishield and Sputnik and those in pipeline like Zydus Cadila, BioE, Novovax and a few others, the central government has a firm pipeline of 2.16 billion dose before the end of the year.
From May 1, all Indians above 18 years of age are now eligible for vaccination. So far, more than 185 million people have been vaccinated across India, at the fastest pace in the word.
2. Oxygen Availability
Think of the scale of the challenge in this way. Before the second wave, the daily medical oxygen demand of India was around 900 MT/day. Within days it shot up to 9,000 MT/day. A few days were indeed very painful. But significant action has been taken to address the situation.
Now that production issues have been managed, and although transportation logistics is within the domain of states, yet all central ministries have been mobilized to pool in their resources. For example, Oil and Gas PSUs under the Ministry of Petroleum and Natural Gas are specifically working to find transportation solutions for Liquid Oxygen.
Currently, there are 12 tankers and 20 ISO containers with the capacity of 650 MT. The figure is going to improve substantively, with the numbers likely to go up to 26 tankers and 117 ISO containers by the end of this month, with the capacity of 2314 MT. Overall, the capacity of oxygen tankers was 12,480 MT in March and their number was 1040. Now, the capacity of tankers has gone up to 23,056 MT and their number has increased to 1681. Availability of medical oxygen cylinders has increased from 435,000 in March 2020 to 1.12 million on May 21.
Additionally, liquid oxygen has also been imported from abroad, 3,500 MT will be delivered over 3 months. In addition, 2285 MT of LMO has been imported from UAE, Bahrain, Kuwait and France, a part of which has already arrived.
3. Drugs, Pharmaceuticals, PPE, N-95 Masks, Ventilators
Production of Remdesivir has gone up from 3.7 million 12 April 2021 to 10.1 million on 4th May 2021. The number of plants producing Remdesivir has also gone up from 20 on 12 April 2021 to 57 on 4 May 2021. Additional thousands of Tocilizumab have been procured and issued across the country.
The Drug Regulator has approved a new anti-COVID drug developed by DRDO for emergency use. This drug has shown tremendous promise in curing COVID and drastically reducing need for hospitalization.
16.19 million PPE Kits and 41 million N-95 masks have also been supplied to the States for their front-line workers. 38,103 new ventilators, through standard route, have also been supplied to the states.
4. Testing Infrastructure
Approximately 2,463 testing facilities with a combined daily testing capacity of 1.5 million are functioning now as compared to just a single laboratory in January 2020. In addition, from a stage of no indigenous manufacturers of COVID lab diagnostics or testing machines, presently an indigenous production capacity exists of more than 1 million kits/day.
5. Hospitals and Care Facilities
Total 1.86 million beds, including the 4,68,974 beds in the Dedicated COVID Hospitals, exists as of today. Just before lockdown last year, there were just 10,180 isolation beds.
Similar capacity augmentation has been done for ICU beds, with increase from just 2,168 before lockdown to now over 92,000.
Covid Care Railway Coaches as Isolation Units are now functional in 17 diverse locations in 7 states spread over the country. 70,000 isolation beds made available by Railways in more than 4,400 Covid Care Coaches
6. Support to Citizens
About 3 billion dollars has already transferred directly into Punjab farmers’ account against sale of their Wheat crop. For the First Time, Farmers of Punjab have received payments directly into their bank accounts
Over 100,000 MT of food grains has been distributed to over 20 million beneficiaries in 12 States in the first 10 days itself of the scheme under Pradhan Mantri Garib Kalyan Anna Yojana. This scheme is an extension of the same scheme floated last year in the first wave in which almost 80 million people benefitted.
7. Delivery of Global Aid
As of May 11, 8,900 Oxygen Concentrators, 5,043 Oxygen Cylinders, 18 Oxygen Generation Plants, 5,698 ventilators/ Bi PAP and more than 340,000 lakh Remdesivir vials were received as part of global aid to India and have been delivered/ dispatched to States and UTs.
8. Financial Support to States & Local Governments
Centre has released 1.5 billion dollars to Panchayats in 25 States as untied grants. Maximum number of days of overdraft in a quarter for state governments has been increased from 36 to 50 days in view of the pandemic emergency.
Central government has also decided to provide an additional amount of up to 2 billion dollars to States as interest free 50-year loan for spending on capital projects.
9. Financial Steps to Improve Access to Emergency Medical Services
Term Liquidity Facility of almost 8 billion dollars set up with tenure of up to 3 years, at repo rate, to ease access to emergency health services, for ramping up COVID-related health infrastructure and services.
For the MSME and other unorganized sector entities a total of 2.5 billion dollars has been set aside, with a limit of almost 15,000 dollars available to per borrower. These loans would be available at nominal interest rates and will majorly help in keeping the economic activity going.
10. PM-CARES Fund Disbursal
Utilizing PM CARES find, more than 1,200 medical oxygen generating plants have been sanctioned, in addition to those already installed. This will ensure every district of the country has at least one dedicated plant. Simultaneously, 150,000 lakh Oxygen Concentrators have been purchased using the same fund to augment capacity.
PM CARES fund has also been utilized to procure and deploy 50,000 ‘Made in India’ ventilators.
Almost 150 million dollars from PM CARES Fund has been mobilized for migrant relief.
The PM CARES will also be used for procurement of 66 million doses of vaccines for COVID-19 under Phase-I for the Healthcare Workers and other Frontline Workers. This was apart from money sanctioned as a helping hand to catalyze vaccine development.
11. Leading from the front – Review meetings
Prime Minister Narendra Modi himself has been leading the mobilization of the decision makers at all levels to keep the government machinery in top gear. He has addressed the nation 10 times so far, held multiple rounds of meetings with Chief Ministers – during the first wave, before the second wave even started and during the second wave. Modi has been personally interacting with oxygen manufacturers, drug makers, nitrogen plant owners (to transition them to oxygen manufacturing), top medical professionals, the Armed Forces to mobilize them for relief, vaccine manufacturers and a host of other stakeholders.
Just yesterday, on May 18, Modi held a meeting with the District Collectors – the field commanders in a way – to hear from them first hand as to what is happening in the villages.
The entire government machinery, the cabinet, the secretaries and the empowered groups are similarly mobilized.
India has waged a difficult, and at times, a painful battle against the pandemic. But the front-line workers, the health professionals in particular and the people in general are waging a heroic battle. It is this collective will of the people that shall soon bear results.
Despite global skepticism, India distributed over 100 million HCQ tablets for Covid-19
The Indian government has distributed millions of tablets of a controversial drug as part of its Covid-19 relief programme.
On Feb. 2, the government informed parliament (pdf) that it has distributed 111.6 million pills of hydroxychloroquine or HCQ. The medicine is used for the treatment of autoimmune diseases or malaria.
At the start of the pandemic, in early 2020, there were some global claims that HCQ was effective against coronavirus. However, by mid-2020, research by the World Health Organization (WHO) and several countries had quashed these claims.about:blank
In India, however, most states have received HCQ tablets from the central government, according to official data.
The controversial HCQ
In March 2020, the Indian Council of Medical Research (ICMR) began a “demonstration study” on the efficacy of HCQ as a preventing drug against coronavirus. The same month, the Narendra Modi government released an advisory for healthcare workers attending to Covid-19 patients and household contacts of confirmed cases to take the medicine.about:blank
The tablet was also endorsed by former US president Donald Trump in May as a treatment for Covid-19, despite scant evidence that it actually worked against the virus. In fact, in May, the US imported around 50 million HCQ tablets from India.
On May 22, the Modi government released a second advisory asking frontline workers, including the police and people conducting door-to-door surveys to estimate Covid-19 cases, to take HCQ to prevent infection.
By then, several global medical research bodies had started raising red flags against the use of HCQ for these purposes. ICMR, however, defended the use of the drug saying it showed that HCQ was useful in treating Covid-19. “What we have been doing in India is different from the studies done anywhere else in the world in the sense that we have been checking whether it could work as a prophylactic medicine, whereas everywhere else it was given to positive patients as a treatment option. The results look like favourable in our population,” an ICMR official told national daily Hindustan Times in May defending the use of the medicine in India.about:blank
By June, the US, France, and Australia had suspended their clinical trials on the drug’s ability to fight coronavirus, adding to the concerns around it’s safety and efficacy.
Currently, most nations are sceptical about the use as the HCQ in the absence of definitive evidence.
As per a study released by the New England Journal of Medicine on Feb. 4, post exposure therapy with HCQ did not prevent Covid-19 infection. The analysis included 2,314 healthy contacts of 672 patients with Covid-19 who were identified between March 17 and April 28, 2020.
Ivermectin Wins in India
News of India’s defeat of the Delta variant should be common knowledge. It is just about as obvious as the nose on one’s face. It is so clear when one looks at the graphs that no one can deny it.
Yet, for some reason, we are not allowed to talk about it. Thus, for example, Wikipedia cannot mention the peer-reviewed meta-analyses by Dr. Tess Lawrie or Dr. Pierre Kory published in the American Journal of Therapeutics.
Wikipedia is not allowed to publish the recent meta-analysis on Ivermectin authored by Dr. Andrew Hill.
Furthermore, it is not allowed to say anything concerning www.ivmmeta.com showing the 61 studies comprising 23,000 patients which reveal up to a 96% reduction in death [prophylaxis] with Ivermectin.
One can see the bias in Wikipedia by going on the “talk” pages for each subject and reading about the fierce attempts of editors to add these facts and the stone wall refusals by the “senior” editors who have an agenda. And that agenda is not loyalty to your health.
The easy way to read the “talk” page on any Wikipedia subject is to click the top left “talk” button. Anyone can then review the editors’ discussions.
There is a blackout on any conversation about how Ivermectin beat COVID-19 in India. When I discussed the dire straits that India found itself in early this year with 414,000 cases per day, and over 4,000 deaths per day, and how that evaporated within five weeks of the addition of Ivermectin, I am often asked, “But why is there no mention of that in the news?”
Yes, exactly. Ask yourself why India’s success against the Delta variant with Ivermectin is such a closely guarded secret by the NIH and CDC. Second, ask yourself why no major media outlets reported this fact, but instead, tried to confuse you with false information by saying the deaths in India are 10 times greater than official reports.
Perhaps NPR is trying so hard because NPR is essentially a government mouthpiece. The US government is “all-in” with vaccines with the enthusiasm of a 17th century Catholic Church “all-in” with a Geocentric Model of the Universe disputing Galileo. Claiming that India’s numbers are inaccurate might distract from the overwhelming success of Ivermectin.
But in the end, the truth matters. It mattered in 1616, and it matters in 2021.
The graphs and data from the Johns Hopkins University CSSE database do not lie.
On the contrary, they provide a compelling trail of truth that no one can dispute, not even the NIH, CDC, FDA, and WHO.
Just as Galileo proved with his telescope that the earth was NOT the center of the Universe in 1616; today, the data from India shows that Ivermectin is effective, much more so than the vaccines. It not only prevents death, but it also prevents COVID infections, and it also is effective against the Delta Variant.
In 1616, you could not make up the telescopic images of Jupiter and its orbiting moons, nor could you falsify the crescent-shaped images of Venus and Mercury. These proved that the earth was NOT the center of the Universe – a truth the Catholic Church could not allow.
Likewise, the massive drop in cases and deaths in India to almost nothing after the addition of Ivermectin proved the drug’s effectiveness. This is a truth that the NIH, CDC, and FDA cannot allow because it would endanger the vaccine policy.
Never mind that Ivermectin would save more lives with much less risk, much less cost, and it would end the pandemic quickly.
Let us look at the burgundy-colored graph of Uttar Pradesh. First, allow me to thank Juan Chamie, a highly-respected Cambridge-based data analyst, who created this graph from the JHU CSSE data. Uttar Pradesh is a state in India that contains 241 million people. The United States’ population is 331 million people. Therefore, Uttar Pradesh can be compared to the United States, with 2/3 of our population size.
This data shows how Ivermectin knocked their COVID-19 cases and deaths – which we know were Delta Variant – down to almost zero within weeks. A population comparable to the US went from about 35,000 cases and 350 deaths per day to nearly ZERO within weeks of adding Ivermectin to their protocol.
By comparison, the United States is the lower graph. On August 5, here in the good ol’ USA, blessed with the glorious vaccines, we have 127,108 new cases per day and 574 new deaths.
Let us look at the August 5 numbers from Uttar Pradesh with 2/3 of our population. Uttar Pradesh, using Ivermectin, had a total of 26 new cases and exactly THREE deaths. The US without Ivermectin has precisely 4889 times as many daily cases and 191 times as many deaths as Uttar Pradesh with Ivermectin.
It is not even close. Countries do orders of magnitude better WITH Ivermectin. It might be comparable to the difference in travel between using an automobile versus a horse and buggy.
Uttar Pradesh on Ivermectin: Population 240 Million [4.9% fully vaccinated]
COVID Daily Cases: 26
COVID Daily Deaths: 3
The United States off Ivermectin: Population 331 Million [50.5% fully vaccinated]
COVID Daily Cases: 127,108
COVID Daily Deaths: 574
Let us look at other Ivermectin using areas of India with numbers from August 5, 2021, compiled by the JHU CSSE:
Delhi on Ivermectin: Population 31 Million [15% fully vaccinated]
COVID Daily Cases: 61
COVID Daily Deaths: 2
Uttarakhand on Ivermectin: Population 11.4 Million [15% fully vaccinated]
COVID Daily Cases: 24
COVID Daily Deaths: 0
Now let us look at an area of India that rejected Ivermectin.
Tamil Nadu announced they would reject Ivermectin and instead follow the dubious USA-style guidance of using Remdesivir. Knowing this, you might expect their numbers to be closer to the US, with more cases and more deaths. You would be correct. Tamil Nadu went on to lead India in COVID-19 cases.
Tamil Nadu continues to suffer for its choice to reject Ivermectin. As a result, the Delta variant continues to ravage their citizens while it was virtually wiped out in the Ivermectin-using states. Likewise, in the United States, without Ivermectin, both the vaccinated and unvaccinated continue to spread the Delta variant like wildfire.
Tamil Nadu off Ivermectin: Population 78.8 Million [6.9% fully vaccinated]
COVID Daily Cases: 1,997
COVID Daily Deaths: 33
Like the JHU CSSE data, Galileo’s telescope did not lie either, and the truth can usually be found in plain sight. Ivermectin works, and it works exceedingly well. Harvard-trained virologist Dr. George Fareed and his associate, Dr. Brian Tyson of California’s Imperial Valley, have saved 99.9% of their patients with a COVID Cocktail that includes Ivermectin. They have released versions of their new book published in the Desert Review that everyone should read.
I could talk about how every one of my patients who used Ivermectin recovered rapidly, about my most recent case who felt 90% better within 48 hours of adding the drug, but I won’t. I could write about how Wikipedia censors more than Pravda, about how you should always read the “talk” section of EVERY Wikipedia article to go behind the scenes and understand what the editors DO NOT want you to read, but I will refrain.
I could write about VAERS and how it is so much easier to navigate by following Open VAERS or how Wikipedia has unfairly portrayed Dr. Peter McCullough, one of the world’s sharpest and most credible doctors. But I will hold back.
I could recite the history of early outpatient treatment of COVID-19 with repurposed drugs, including Ivermectin, with all the specifics, and EXACTLY WHY this lifesaving information has been censored, but instead, I will leave researching these topics to each of you readers as individuals.
Because you already know what will happen if you simply sit back and swallow what the media are feeding you. You MUST question what the government tells you, and always DO YOUR OWN research.
Following the 1616 Inquisition of Galileo, the Pope banned all books and letters that argued the sun was the center of the Universe instead of the Earth.
YouTube and Wikipedia both consider Ivermectin for COVID as heresy.
“YouTube doesn’t allow content that spreads medical misinformation that contradicts local health authorities or the World Health Organization’s (WHO) medical information about COVID-19… Treatment misinformation: claims that Ivermectin is an effective treatment for COVID-19.”
Wikipedia defines heresy as:
“any belief or theory that is strongly at variance with established beliefs or customs, in particular the accepted beliefs of a church or religious organization. The term is usually used in reference to violations of important religious teachings, but is also used of views strongly opposed to any generally accepted ideas. A heretic is a proponent of heresy.”
Heresy is disagreeing with the government, or their health authority, even if they are all wrong and even if their policies harm people. Today we no longer call it heresy; it is labeled as misinformation.
Galileo was found guilty of heresy and sentenced on June 22, 1633, to formal imprisonment, although this was commuted to house arrest, under which he remained for the rest of his life.
Indian state with 240 million people completely eradicated covid with ivermectin
How did an Indian state with more than 240 million residents beat the Wuhan coronavirus (Covid-19)? Simple. Its people took ivermectin.
Uttar Pradesh, located in northern India, has officially declared that all 33 of its districts are now “covid-free” thanks to a benevolent effort by the leaders there to provide everyone with “horse dewormer.”
The recovery rate for the Chinese Virus in Uttar Pradesh is a whopping 98.7 percent, which can be directly attributed to the large-scale prophylactic use of ivermectin.
According to the Western media and medical establishment, there is “no evidence” that ivermectin provides any benefits in the fight against Chinese Germs. According to real-life, on-the-ground proof in India, however, ivermectin really has been a miracle.
It was not too long ago that ivermectin was touted by the Journal of Antibiotics as a “wonder drug” for treating intestinal parasites. The inventors of ivermectin were also awarded a Nobel Prize for discovering the substance.
Now, however, ivermectin is being vilified as “dangerous” and “high-risk” by the media and the government. We are constantly being told that ivermectin is just for cattle or horses, even though the Food and Drug Administration (FDA) approved it for human use back in 1996.
Areas of India that chose “vaccines” instead of ivermectin seeing massive surge in new cases
Back in May and June 2020, ivermectin was widely administered to all respiratory care professionals working in the Uttar Pradesh district of Agra. At the time, this was an experiment to see how recipients fared.
It was observed, according to Dr. Anshul Pareek, that “none of them developed Covid-19 despite being in daily contact with patients who had tested positive for the virus.”
Following this successful trial, the state government decided to officially sanction the use of ivermectin as a Chinese Virus remedy, not only for medical workers but later for the general public.
“Despite being the state with the largest population base and a high population density, we have maintained a relatively low positivity rate and cases per million of population,” Pareek explained.
In August, officials in Uttar Pradesh issued a notification advising doctors there to take 12 mg tablets of ivermectin “to contain the impact of the pandemic.” This recommendation turned out to be a major success.
“This medicine is quite effective in protecting from COVID-19,” the government admitted. “Therefore, we appeal each and every citizen to have this tablet.”
In the tiny southern Indian state of Kerala, meanwhile, new “cases” of the Fauci Flu have been soaring. The reason is that instead of going with ivermectin, Kerala instead opted for “vaccines,” which are spreading more disease.
“Kerala included ivermectin in the state’s COVID treatment guideline in April but restricted its use to severe cases or those with associated disease, meaning it was reserved as a late treatment, if used at all,” WND reported.
“Kerala abandoned ivermectin use altogether on Aug. 5.”
Kerala is more the exception than the norm, though. Across India as a whole, the vaccination rate is currently around 5.8 percent, making it one of the least injected countries in the world.
“There’s a claim that ivermectin is also effective against the common flu and many other viral infections,” wrote one commenter at WND. “If that’s true, it’s no wonder big pharma wants to keep it suppressed.”
“Ivermectin is perfectly safe, but the government does not want you to know that,” noted another. “The drug has little side effects, has been prescribed millions of times, and is known to kill 21 different viruses, including SARS-CoV-2.”
Ivermectin has been safely used for years and is off-patent.
I want to make this point, I am not a medical doctor. So take what I say any way you want. I have been a registered nurse for 19 years, eleven of those in the ICU. I have also spent my life pursuing a greater understanding of anatomy and physiology. In the last 18 months I have cared for hundreds of COVID positive patients. I also want to make several statements about our medical system in the US. Medicine and health care has become a tool of both political parties. Fear is being used as a political tool. Health care is big business in the US. We are an incredibly litigious society. Big pharma is not necessarily our friend. Big pharma wants to make money. Our FDA certification of medicine drives the price of medicine up astronomically. Ivermectin and Hydroxychloroquine are very cheap to administer. Remdesivir and convalescent plasma are very expensive therapies. Now that I have made all of these caveats you will find it easier to understand some of the events that have been taking place in the US. Ivermectin and Hydroxychloroquine have not been cleared for use in the treatment of the coronavirus. They have been on the market for decades in the treatments of other ailments, though and have been deemed safe for these treatment modalities. So my question is why are they not safe for covid? Kind of makes you wonder. Could it be greed, power and politics playing roles here? So, now we have Ivermectin treatment in India. Apparently India has put its people’s well being before profits and politics, how refreshing. So can we believe our lying eyes and ears? Does this drug work for covid? I am afraid that only those in the know will actually ever know. It is a terrible thing when profits and power have become more important that human life. I guess I shouldn’t be surprised being a student of history. We as a species have held little value for life of any kind and we have treated our world like a garbage can and playground for thousands of years.
npr.org, “The Mystery Of India’s Plummeting COVID-19 Cases,” By Lauren Frayer; newsable.asiannetnews.com, “Coronavirus: What is India doing to battle the COVID-19 pandemic?” By Akhilesh Mishra; qz.com, “Despite global scepticism, India distributed over 100 million HCQ tablets for Covid-19,” By Niharika Sharma; the burningplatform.com, “India’s Ivermectin Blackout,” BY justus R. Hope MD; dreddymd.com, “Indian state with 240 million people completely eradicated covid with ivermectin,” By Dr. Eddy Bettermann, MD;
covid-19 and Healthcare Postings